Yin, Xianyong https://orcid.org/0000-0001-6454-2384
Chan, Lap Sum https://orcid.org/0000-0003-3206-9064
Bose, Debraj https://orcid.org/0000-0002-3177-6608
Jackson, Anne U. https://orcid.org/0000-0002-9672-2547
VandeHaar, Peter https://orcid.org/0000-0002-8072-9461
Locke, Adam E. https://orcid.org/0000-0001-6227-198X
Fuchsberger, Christian
Stringham, Heather M. https://orcid.org/0000-0002-2991-6392
Welch, Ryan https://orcid.org/0000-0001-6378-1295
Yu, Ketian https://orcid.org/0000-0001-9994-3399
Fernandes Silva, Lilian https://orcid.org/0000-0003-0225-842X
Service, Susan K.
Zhang, Daiwei https://orcid.org/0000-0002-5019-622X
Hector, Emily C. https://orcid.org/0000-0003-1488-3150
Young, Erica https://orcid.org/0000-0002-3671-211X
Ganel, Liron https://orcid.org/0000-0002-8762-622X
Das, Indraniel
Abel, Haley
Erdos, Michael R. https://orcid.org/0000-0002-6603-1833
Bonnycastle, Lori L.
Kuusisto, Johanna
Stitziel, Nathan O. https://orcid.org/0000-0002-4963-8211
Hall, Ira M. https://orcid.org/0000-0003-4442-6655
Wagner, Gregory R.
,
Ripatti, Samuli https://orcid.org/0000-0002-0504-1202
Palotie, Aarno https://orcid.org/0000-0002-2527-5874
Kang, Jian
Morrison, Jean https://orcid.org/0000-0003-4829-8283
Burant, Charles F.
Collins, Francis S.
Ripatti, Samuli https://orcid.org/0000-0002-0504-1202
Palotie, Aarno https://orcid.org/0000-0002-2527-5874
Freimer, Nelson B. https://orcid.org/0000-0003-3586-6587
Mohlke, Karen L. https://orcid.org/0000-0001-6721-153X
Scott, Laura J. https://orcid.org/0000-0002-4886-5084
Wen, Xiaoquan https://orcid.org/0000-0001-8990-2737
Fauman, Eric B. https://orcid.org/0000-0002-9739-0249
Laakso, Markku https://orcid.org/0000-0002-3394-7749
Boehnke, Michael https://orcid.org/0000-0002-6442-7754
Funding for this research was provided by:
American Diabetes Association
Article History
Received: 13 August 2021
Accepted: 23 February 2022
First Online: 28 March 2022
Competing interests
: A.E.L. is an employee and stockholder of Regeneron Pharmaceuticals. L.G. is an employee of Genentech, Inc. and stockholder of Roche. N.O.S. has received research funding from Regeneron Pharmaceuticals unrelated to this work. G.R.W. is a stockholder of Metabolon, Inc. E.B.F. is an employee and stockholder of Pfizer. The remaining authors declare no competing interests.